Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment resistant disorders, generalized anxiety disorders, and bipolar depression; and SAGE-324, a …
Over the last 12 months, insiders at Sage Therapeutics, Inc. have bought $0 and sold $0 worth of Sage Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Sage Therapeutics, Inc. have bought $1.15M and sold $519,413 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $37,279 was made by Barrett Elizabeth (director) on 2023‑08‑09.
2023-08-09 | Barrett Elizabeth | director | 2,000 0.0032% | $18.64 | $37,279 | +2.79% | ||
2023-05-09 | Barrett Elizabeth | director | 1,000 0.0017% | $50.50 | $50,500 | -58.22% | ||
2023-02-10 | Sale | JONAS JEFFREY M | director | 11,643 0.0193% | $44.61 | $519,413 | -41.07% | |
2022-11-10 | Greene Barry E | President and CEO | 14,500 0.024% | $34.48 | $500,022 | +19.17% | ||
2022-05-05 | Golumbeski George | 8,000 0.0136% | $31.45 | $251,563 | +26.48% | |||
2021-08-05 | Greene Barry E | President and CEO | 23,640 0.0401% | $43.15 | $1.02M | -10.58% | ||
2021-06-16 | STARR KEVIN P | director | 17,842 0.0311% | $56.05 | $999,983 | -24.87% | ||
2021-06-16 | Greene Barry E | President and CEO | 8,800 0.0154% | $56.32 | $495,627 | -24.87% | ||
2021-06-16 | FRATES JAMES M | director | 1,810 0.0031% | $55.10 | $99,735 | -24.87% | ||
2019-12-09 | Robichaud Albert | Chief Scientific Officer | 25,000 0.0494% | $64.16 | $1.6M | -16.96% | ||
2019-12-09 | JONAS JEFFREY M | President & CEO | 7,500 0.0148% | $64.20 | $481,500 | -16.96% | ||
2019-08-15 | Sale | FRATES JAMES M | director | 8,000 0.0154% | $160.58 | $1.28M | -58.68% | |
2019-05-29 | Sale | JONAS JEFFREY M | President & CEO | 1,075 0.0021% | $170.61 | $183,401 | -20.75% | |
2019-05-28 | Sale | JONAS JEFFREY M | President & CEO | 84,661 0.1656% | $174.83 | $14.8M | -20.45% | |
2019-05-24 | Sale | JONAS JEFFREY M | President & CEO | 40,356 0.0786% | $175.08 | $7.07M | -20.51% | |
2019-05-23 | Sale | JONAS JEFFREY M | President & CEO | 53,908 0.1047% | $174.51 | $9.41M | -20.45% | |
2019-05-22 | Sale | Cloonan Michael | Chief Business Officer | 25,000 0.0485% | $175.00 | $4.38M | -20.71% | |
2019-05-10 | Sale | Cook Anne Marie | SVP, GC & Secretary | 15,000 0.0293% | $166.14 | $2.49M | -15.12% | |
2019-05-06 | Sale | FRATES JAMES M | director | 8,000 0.0148% | $162.22 | $1.3M | -17.11% | |
2019-03-21 | Sale | PAUL STEVEN M | director | 7,879 0.0166% | $161.04 | $1.27M | -1.30% |
STARR KEVIN P | director | 320659 0.5216% | $2.48M | 1 | 4 | <0.0001% |
Robichaud Albert | Chief Scientific Officer | 136400 0.2219% | $1.05M | 2 | 6 | +14.96% |
PAUL STEVEN M | director | 122400 0.1991% | $944,928.00 | 1 | 14 | +46.89% |
JONAS JEFFREY M | director | 121981 0.1984% | $941,693.32 | 3 | 10 | <0.0001% |
Greene Barry E | President and CEO | 46940 0.0763% | $362,376.80 | 3 | 0 | <0.0001% |
$587,109,125 | 90 | 3.17% | $527.16M | |
$14,527,743 | 76 | 38.40% | $447.93M | |
$84,871,118 | 57 | 17.71% | $412.59M | |
$24,384,691 | 42 | -30.27% | $455.92M | |
$54,828,550 | 26 | -13.88% | $493.09M |
Increased Positions | 78 | +37.32% | 12M | +22.92% |
Decreased Positions | 84 | -40.19% | 12M | -23.18% |
New Positions | 26 | New | 6M | New |
Sold Out Positions | 26 | Sold Out | 2M | Sold Out |
Total Postitions | 203 | -2.87% | 51M | -0.26% |
Blackrock, Inc. | $35,410.00 | 7.95% | 4.85M | -540,196 | -10.02% | 2024-12-31 |
Vanguard Group Inc | $35,319.00 | 7.93% | 4.84M | -922,280 | -16.01% | 2024-12-31 |
Morgan Stanley | $33,539.00 | 7.53% | 4.59M | +4M | +468.05% | 2024-12-31 |
Bellevue Group Ag | $32,563.00 | 7.31% | 4.46M | 0 | 0% | 2024-12-31 |
Fmr Llc | $30,054.00 | 6.75% | 4.12M | -1M | -21.89% | 2024-12-31 |
Caligan Partners Lp | $22,284.00 | 5% | 3.05M | +3M | New | 2024-12-31 |
Rtw Investments, Lp | $21,917.00 | 4.92% | 3M | -3M | -46.31% | 2024-12-31 |
Millennium Management Llc | $11,854.00 | 2.66% | 1.62M | +124,720 | +8.32% | 2024-12-31 |
Acadian Asset Management Llc | $11,574.00 | 2.6% | 1.59M | +638,575 | +67.44% | 2024-12-31 |
Boothbay Fund Management, Llc | $10,136.00 | 2.28% | 1.39M | +1M | New | 2024-12-31 |